Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein

Abstract Background Therapeutic antibodies for the treatment of neurological disease show great potential, but their applications are rather limited due to limited brain exposure. The most well-studied approach to enhance brain influx of protein therapeutics, is receptor-mediated transcytosis (RMT)...

Descripció completa

Dades bibliogràfiques

Autors principals:	Marie-Lynn Cuypers, Tom Jaspers, Jarne Clerckx, Simon Leekens, Christopher Cawthorne, Guy Bormans, Frederik Cleeren, Nick Geukens, Bart De Strooper, Maarten Dewilde
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-01-01
Col·lecció:	Fluids and Barriers of the CNS
Matèries:	Blood–brain barrier VHH Myelin oligodendrocyte glycoprotein Transferrin receptor Brain half-life extension β-secretase 1
Accés en línia:	https://doi.org/10.1186/s12987-025-00624-1
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!